Glenmark Launches COVID 19 Tablets


Glenmark announce FabiFlu Glenmark Pharmaceuticals Limited has announced the introduction of Favipiravir in India. Under the brand name FabiFlu for the treatment of mild & moderate COVID-19 cases in India. Glenmark received approval from DCGI The Drugs Controller General of India (DCGI) given approval to Glenmark. Glenmark Pharmaceuticals drug firm has launched antiviral drug Favipiravir. It is for the treatment of patients with mild to moderate COVID-19 patients. Under the brand name FabiFlu. Tablets at…